Zydus Lifesciences – Technical Outlook

Zydus Lifesciences has witnessed a strong bullish reversal after forming a higher base near the ₹900–950 zone. The stock recently delivered a decisive breakout above its medium-term consolidation range and is now trading around ₹1,140, indicating renewed buying momentum. The breakout has been accompanied by sustained higher highs and higher lows, reflecting a positive price structure and improving investor sentiment. From a moving average perspective, the technical setup remains favorable. The stock is trading comfortably above its 20-day, 50-day, 100-day, and 200-day moving averages, with the shorter-term averages positioned above the longer-term averages. This alignment signals a strong medium- to long-term uptrend. After the sharp rally, the stock is currently consolidating near recent highs, suggesting healthy profit booking rather than any major trend reversal. Immediate resistance is placed around ₹1,145–1,160. A decisive breakout above this zone could trigger fresh buying interest and open the doors for an upward move towards ₹1,200, followed by ₹1,250 in the coming weeks. On the downside, ₹1,090–1,070 is likely to act as an immediate support zone, while stronger support is placed near ₹1,020, where the short-term moving averages are expected to provide buying support. Overall, the chart structure remains constructive, and the primary trend continues to favor the bulls. Traders may consider a buy-on-dips approach as long as the stock sustains above the ₹1,090 support zone. A sustained move above ₹1,160 would further strengthen the bullish outlook and increase the probability of continuation towards higher resistance levels. However, a close below ₹1,070 could delay the ongoing uptrend and lead to a deeper consolidation before the next directional move. $ZYDUSLIFE